TORNTPHARM \u2014 Recent Activity

A Look At Xeris Biopharma Holdings (XERS) Valuation As It Fights To Protect Recorlev Exclusivity

Xeris Biopharma Holdings (XERS) has filed a patent infringement lawsuit to block Torrent Pharmaceuticals and Somerset Therapeutics from producing generic versions of Recorlev. This move raises questions about future exclusivity and potential effects on investor sentiment. See our latest analysis for Xeris Biopharma Holdings. The lawsuit news follows a sharp 9.2% one-day share price decline and a 16.7% year-to-date share price pullback. However, the 1-year total shareholder return of about...

Click to open →

Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2026 Earnings Call Highlights: Robust Revenue ...

Torrent Pharmaceuticals Ltd (BOM:500420) reports an 18% revenue increase and strategic expansion through JB Pharma acquisition, despite challenges in Germany.

Click to open →

India's Torrent Pharma lines up mega $1.4 billion acquisition-funding bond sale, bankers say

By Dharamraj Dhutia MUMBAI, Jan 8 (Reuters) - India's Torrent Pharmaceuticals is set to raise up to 125 billion rupees ($1.4 billion) through short-duration bond sales in January, in one of the latest

Click to open →

Torrent Pharmaceuticals Ltd (BOM:500420) Q2 2026 Earnings Call Highlights: Strong Revenue ...

Torrent Pharmaceuticals Ltd (BOM:500420) reports a 14% revenue increase, driven by robust performance in India and Brazil, despite challenges in Germany and the U.S.

Click to open →

India's Torrent Pharma to proceed with $1.6 billion bond issue after regulatory nod, bankers say

By Dharamraj Dhutia MUMBAI (Reuters) -India's Torrent Pharmaceuticals will proceed with its plan to sell bonds worth as much as 140 billion rupees ($1.6 billion) after the country's competition

Click to open →

Sector Update: Financial Stocks Advance Premarket Monday

Financial stocks were advancing premarket Monday with the Financial Select Sector SPDR Fund (XLF) 0.

Click to open →

Torrent Pharmaceuticals to acquire stake in JB Pharma for $3bn

Torrent intends to buy 2.8% of equity shares from JB employees at the same price per share as offered to KKR.

Click to open →

India's Torrent Pharma to acquire controlling stake in JB Chem and Pharma

(Reuters) -India's Torrent Pharmaceuticals said on Sunday it will acquire a 46.39% controlling stake in smaller peer JB Chemicals and Pharmaceuticals from New York-based investment firm KKR, and plans to merge the two drugmakers. The transaction, announced in a joint statement released by the three companies, implies a total equity valuation of 256.89 billion rupees ($3.01 billion) for JB Pharma on a fully diluted basis. Under the terms of the deal, Torrent will initially acquire an equity sta

Click to open →

Torrent Pharmaceuticals Ltd (BOM:500420) Q4 2025 Earnings Call Highlights: Strong Revenue ...

Torrent Pharmaceuticals Ltd (BOM:500420) reports an 8% revenue increase, driven by robust growth in India and the US, despite currency headwinds in Brazil.

Click to open →